BCAX vs LH · $1.51B cap vs P/E 23, rev $7.27B
Bicara Therapeutics Inc. Common Stock (BCAX) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company listed on NASDAQ.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
BCAX does not have a complete income-statement cache yet.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
BCAX currently screens at market cap $1.51B. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the BCAX and LH stock pages for the full models.
Not investment advice.